Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.36 - $9.25 $7,632 - $196,100
-21,200 Reduced 13.48%
136,045 $47,000
Q2 2022

Aug 12, 2022

BUY
$0.38 - $1.05 $26,161 - $72,287
68,845 Added 77.88%
157,245 $66,000
Q1 2022

May 13, 2022

SELL
$0.52 - $1.3 $40,924 - $102,310
-78,700 Reduced 47.1%
88,400 $61,000
Q4 2021

Feb 11, 2022

BUY
$0.66 - $1.18 $110,286 - $197,178
167,100 New
167,100 $110,000
Q2 2021

Aug 13, 2021

SELL
$1.31 - $2.14 $289,510 - $472,940
-221,000 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$1.85 - $3.04 $118,048 - $193,982
63,810 Added 40.59%
221,000 $435,000
Q4 2020

Feb 10, 2021

BUY
$1.58 - $2.37 $123,211 - $184,817
77,982 Added 98.45%
157,190 $373,000
Q3 2020

Nov 13, 2020

BUY
$1.86 - $3.15 $103,155 - $174,699
55,460 Added 233.54%
79,208 $156,000
Q2 2020

Aug 13, 2020

BUY
$2.53 - $4.08 $60,082 - $96,891
23,748 New
23,748 $61,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.